Početna › KOPB › Texas › Dallas
Kliničke studije za KOPB u gradu Dallas, TX
12 studija za KOPB traži sudionike na lokacijama u gradu Dallas i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.
Službeni tekst studije (engleski)
Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
U tijeku regrutacijaFaza 3
- Research Site, Dallas
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
U tijeku regrutacijaFaza 3
- IntraCare- Site Number : 8400034, Dallas
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
U tijeku regrutacijaFaza 3
- Texas Health Presbyterian Hospital Dallas- Site Number : 8400032, Dallas
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
U tijeku regrutacija
- University of Texas Southwestern, Dallas
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
U tijeku regrutacijaFaza 2
- Research Site, Dallas
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
U tijeku regrutacijaFaza 3
- Research Site, Dallas
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
U tijeku regrutacijaFaza 2/3
- Alina Clinical Trials, LLC., Dallas
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
U tijeku regrutacijaFaza 3
- GC2501 Study Site 109, Dallas
STRIVE Post-Market Registry Study
U tijeku regrutacijaOpažajna studija
- Baylor Scott & White Research Institute, Dallas
- University of Texas Southwestern, Dallas
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
U tijeku regrutacijaFaza 3
- GSK Investigational Site, Dallas
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
U tijeku regrutacijaOpažajna studija
- Liver Center of Texas, Dallas
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
U tijeku regrutacijaFaza 3
- GSK Investigational Site, Dallas
Studije za KOPB u drugim gradovima
- Philadelphia, PA23 studija
- Miami, FL18 studija
- Birmingham, AL17 studija
- Boston, MA17 studija
- Houston, TX15 studija
- Orlando, FL15 studija
- Baltimore, MD14 studija
- Chicago, IL14 studija
- Pittsburgh, PA12 studija
- New York City, NY11 studija
- Ann Arbor, MI10 studija
- Detroit, MI9 studija
Ostale studije u gradu Dallas
- Rak dojke55 studija
- Nemikrocelularni karcinom pluća52 studija
- Metastatski karcinom42 studija
- Srčano zatajenje42 studija
- Rak (sve vrste)37 studija
- Rak prostate36 studija
- Kolorektalni rak33 studija
- Debljina30 studija
- Rak jajnika28 studija
- Rak mjehura27 studija
- Rak pluća27 studija
- Rak endometrija24 studija
Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.